Mostafa et al. observed that metformin decreased the level of p-tau in the hippocampus and cortex of mice with scopolamine-induced cognitive impairment, probably through increasing the level of phosphorylated Akt while decreasing that of total Akt (Mostafa et al., 2016). The gene discussed is AKT1; the disease is Cognitive impairment.